What more do we want from neoadjuvant treatment strategies in rectal cancer?

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorHABR-GAMA, Angelita
dc.contributor.authorFERNANDEZ, Laura M.
dc.contributor.authorPEREZ, Rodrigo O.
dc.date.accessioned2015-12-10T16:43:45Z
dc.date.available2015-12-10T16:43:45Z
dc.date.issued2015
dc.description.indexPubMed
dc.identifier.citationCOLORECTAL CANCER, v.4, n.1, p.1-4, 2015
dc.identifier.doi10.2217/CRC.15.5
dc.identifier.eissn1758-1958
dc.identifier.issn1758-194X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/12386
dc.language.isoeng
dc.publisherFUTURE MEDICINE LTD
dc.relation.ispartofColorectal Cancer
dc.rightsrestrictedAccess
dc.rights.holderCopyright FUTURE MEDICINE LTD
dc.subjectcomplete clinical response
dc.subjectcomplete pathological response
dc.subjectneoadjuvant chemotherapy
dc.subjectrectal cancer
dc.subject.otherphase-iii trial
dc.subject.otherlong-course chemoradiation
dc.subject.othertotal mesorectal excision
dc.subject.othershort-course radiotherapy
dc.subject.otherpreoperative radiotherapy
dc.subject.otherfollow-up
dc.subject.othernonoperative treatment
dc.subject.otherpathological response
dc.subject.otherradiation-therapy
dc.subject.otherrandomized-trial
dc.subject.wosOncology
dc.titleWhat more do we want from neoadjuvant treatment strategies in rectal cancer?
dc.typearticle
dc.type.categoryeditorial material
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryArgentina
hcfmusp.affiliation.countryisoar
hcfmusp.author.externalFERNANDEZ, Laura M.:Angelita & Joaquim Gama Inst, Sao Paulo, Brazil; Hosp Britan, Colorectal Surg Div, Buenos Aires, DF, Argentina
hcfmusp.author.externalPEREZ, Rodrigo O.:Angelita & Joaquim Gama Inst, Sao Paulo, Brazil; Univ Sao Paulo, Sch Med, Colorectal Surg Div, Sao Paulo, Brazil; Ludwig Inst Canc Res, Div Mol Genet, Sao Paulo, Brazil
hcfmusp.contributor.author-fmusphcANGELITA HABR GAMA
hcfmusp.description.beginpage1
hcfmusp.description.endpage4
hcfmusp.description.issue1
hcfmusp.description.volume4
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000362679100001
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceBirgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO-2005.02.9017
hcfmusp.relation.referenceHabr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
hcfmusp.relation.referencevan Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3
hcfmusp.relation.referenceGarcia-Aguilar J, 2011, ANN SURG, V254, P97, DOI 10.1097/SLA.0b013e3182196e1f
hcfmusp.relation.referenceBosset JF, 2005, J CLIN ONCOL, V23, P5620, DOI 10.1200/JCO.2005.02.113
hcfmusp.relation.referenceCercek A, 2014, J NATL COMPR CANC NE, V12, P513
hcfmusp.relation.referenceMaas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8
hcfmusp.relation.referenceHabr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e
hcfmusp.relation.referenceAn X, 2013, EUR J CANCER, V49, P843, DOI 10.1016/j.ejca.2012.09.026
hcfmusp.relation.referenceHabr-Gama A, 2013, DIS COLON RECTUM, V56, P264, DOI 10.1097/DCR.0b013e318277e8e4
hcfmusp.relation.referenceFolkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144
hcfmusp.relation.referenceFornaro L, 2014, WORLD J GASTROENTERO, V20, P6081, DOI 10.3748/wjg.v20.i20.6081
hcfmusp.relation.referenceBirgisson H, 2005, J CLIN ONCOL, V23, P6126, DOI 10.1200/JCO.2005.02.543
hcfmusp.relation.referenceBosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829
hcfmusp.relation.referenceGerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376
hcfmusp.relation.referenceSanghera P, 2008, CLIN ONCOL-UK, V20, P176, DOI 10.1016/j.clon.2007.11.013
hcfmusp.relation.referenceBujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506
hcfmusp.relation.referenceSauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836
hcfmusp.relation.referenceAschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911
hcfmusp.relation.referenceDewdney A, 2012, J CLIN ONCOL, V30, P1620, DOI 10.1200/JCO.2011.39.6036
hcfmusp.relation.referenceBorg C, 2014, ANN ONCOL, V25, P2205, DOI 10.1093/annonc/mdu377
hcfmusp.relation.referenceKalady MF, 2009, ANN SURG, V250, P582, DOI 10.1097/SLA.0b013e3181b91e63
hcfmusp.relation.referenceDellas K, 2014, ANN SURG ONCOL, V21, P1352, DOI 10.1245/s10434-013-3412-9
hcfmusp.relation.referenceSchrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904
hcfmusp.relation.referenceGerard JP, 2012, CRIT REV ONCOL HEMAT, V81, P21, DOI 10.1016/j.critrevonc.2011.02.001
hcfmusp.relation.referenceHasegawa J, 2014, CANCER CHEMOTH PHARM, V73, P1079, DOI 10.1007/s00280-014-2417-9
hcfmusp.relation.referenceNgan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597
hcfmusp.relation.referenceSmith FM, 2010, BRIT J SURG, V97, P1752, DOI 10.1002/bjs.7251
hcfmusp.relation.referenceBosset JF, 2014, LANCET ONCOL, V15, P184, DOI 10.1016/S1470-2045(13)70599-0
hcfmusp.relation.referenceChau Ian, 2006, J Clin Oncol, V24, P668, DOI 10.1200/JCO.2005.04.4875
hcfmusp.relation.referenceSclafani F, 2014, J NATL CANC I, V106
hcfmusp.relation.referenceZhou ZR, 2014, SURG ONCOL, V23, P211, DOI 10.1016/j.suronc.2014.10.003
relation.isAuthorOfPublication2ad6fd55-1212-4806-aec6-ad58c73f2ad6
relation.isAuthorOfPublication.latestForDiscovery2ad6fd55-1212-4806-aec6-ad58c73f2ad6
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_HABR-GAMA_What_more_do_we_want_from_neoadjuvant_treatment_2015.PDF
Tamanho:
1.79 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)